Description of cell preparation, flow cytometric analysis (excluding irrelevant cells, and sorting on the basis of two parameters) and confirmation of purity
Figure S1
Description of cell preparation, flow cytometric analysis (excluding irrelevant cells, and sorting on the basis of two parameters) and confirmation of purity
Figure S2
Effect of insufficient gating of non-epithelial populations on epithelial cell profiles
Figure S3
Establishment of the specificity of gating for a multi-Color antigen assay
Figure S4
Use of null cells to establish specificity of antibody binding
Figure S5
Purification of a mammary stem cell-enriched fraction
Figure S6
Report of recovery and fold-enrichment of stem cell activity
Figure S1
An example of a description of cell preparation, flow cytometric analysis (excluding irrelevant cells, and sorting on the basis of two parameters) and confirmation of purity.
The text and images presented in this example have been modified from their original published form (Badders et al., 2009) .
Cell preparation BALB/c mammary epithelial cells were prepared as described (Stingl et al., 2006) , using reagents and protocols from Stem Cell Technologies (Vancouver, Canada), unless otherwise indicated. Briefly, mammary glands were isolated from virgin mice, the lymph nodes removed, and the fat pads chopped finely with surgical scissors (2 min per gram tissue) on ice. The slurry was digested for 6 hours, with rocking, at 37 0 C in Epicult-B supplemented with 5% fetal bovine serum, collagenase/hyaluronidase (cat#07912; 3000 and 1000 U/ml respectively, diluted according to manufacturer), hydrocortisone (cat#07904; final concentration 0.5 μg/mL), and Pen/Strep (as recommended). The resulting mammary organoids were washed, counted (approximately; yield is 0.2 -0.5 x 10 6 / two inguinal mouse mammary glands) and frozen (slow freeze) until use (in DMEM with 10% FBS and 10% DMSO). Prior to flow cytometry, mammary organoids were reduced to single cells by resuspending them at 10 6 cells in 1.0 ml pre-warmed trypsin-EDTA (0.05%, 0.02%; cat# 07910) from Stem Cell Technologies, for exactly 1 min with gentle trituration, followed by the addition of 10 mls cold HF (Hanks' Balanced Salt Solution with 2% serum), and centrifugation (450g, 5 mins). Cells were resuspended in 2 ml of prewarmed dispase (0.5%; cat#07913) with 200 μl DNAse (1 mg/ml; cat#07900), triturated for exactly 1 min, and diluted into cold HF, prior to filtration through a 100 μm mesh filter. Viability was assessed at 60-90%.
Flow cytometry
Cells were resuspended to 1.0 x 10 6 cells/mL of cold PBS. Fluorophore-conjugated antibodies were added and incubated on ice for 1 hr as follows: APC-conjugated rat anti-mouse CD45 (559864; clone number 30-F11; 1 ng/ml) APC-conjugated rat anti-mouse CD31 (551262; clone number MEC13.3; 1 μg/ml), PE-conjugated CD24 (553262; clone number M1/69; 0.5-1 μg/ml), and FITC-conjugated CD49 (555735; clone number GoH3; 30 μl/ml), all from BD Pharmingen. Propidium iodide (2 μg/ml final concentration) was added 15 minutes before cell analysis. Cells were analyzed on the BD Biosciences FACSVantage SE with FACSDiVa option, in D-PBS without Ca 2+ and Mg 2+ . The cytometer was equipped with the following lasers: 633 nM (APC), 488 nM (FITC, PE, PI) and a 100 mm nozzle tip, sheath pressure of 12 psi. Autocompensation was performed with Diva Software, using samples with single-stained fluorophores. Gates were set manually as detailed below. The purity of luminal (L) and basal (B)-cell enriched fractions was determined by immunocytochemical assay of "cytosplats" of cell fractions, using the luminal marker (keratin-5; K5) and the basal cell marker (keratin-8; K8). (Cytosplats were prepared from single cell suspensions of subfractions of flow-sorted mammary epithelial cell populations dried briefly onto microscope slides and fixed in ice-cold methanol and acetone for 4 and 2 minutes, respectively. Cell preparations were blocked in 10% non-immune goat serum and stained as above. The number of K5 and K8 positive cells were quantified by manual counting of at least 100 cells in three random fields per experimental sample.)
The gating tree shows the quantitative data that describes the sequential procedure applied to select out the cells shown in the final analysis (also shown visually in the dot plots). The far right column shows the cumulative fractionation compared to the starting events, whereas the middle column shows the proportion of cells/events carried forward from the previous step (% parent). Cells isolated from basal (B) or luminal (L) fractions were re-analyzed and found to be 94 and 96% pure (not shown). When the fractions were stained for lineage markers (K5, green, basal; K8, red, luminal), less than 1% cells were positive for the basal marker in the luminal fraction, and similarly, less than 1% basal cells were positive for luminal cell markers. The ratio of luminal to basal cells was 1.2 ± 0.2. (Kendrick et al., 2008) .
Figure S3 Example of the Establishment of the Specificity of Gating for a MultiColor Antigen Assay

Assay of CD14 and CD61 expression in three mammary epithelial cell fractions (separated according to their expression of CD24 and Sca1). Text and Figures reprinted from Kendrick et al
Fourth mammary fat pads were harvested from 10 week-old virgin FVB mice. Single mammary cells suspensions were prepared as described (Sleeman et al 2006 (Sleeman et al , 2007 . Mammary cell suspensions at 10 6 cells/ml were stained with anti-CD14-PE (clone rmC5-3; cat# 553740BD; BD Biosciences; 1.0 μg/ml), anti-CD61-FITC (clone 2C9.G2; cat# 553346; BD Biosciences; 2.5 μg/ml), anti-CD24-PE-Cy5 (clone M1/69; cat# 101812; Insight Biotechnology Limited, London, UK; 0.6 μg/ml), anti-Sca-1-APC (clone D7; cat# 108112; Insight Biotechnology Limited; 1.0 μg/ml) and anti-CD45-PE-Cy7 (clone 30-F11; cat# 552848; BD Biosciences, 1.0 μg/ml). Cells were sorted at low pressure (20 psi using a 100 μm nozzle) on a FACSAria flow cytometer (Becton Dickinson, Oxford, UK) equipped with violet (404 nm), blue (488 nm), green (532 nm), yellow (561 nm) and red (635 nm) lasers, and applying FACSDiva software. Both cell sample and collection tubes were maintained at 4°C. Single stained samples were used as compensation controls (the FACSAria automated compensation procedure was used). Dead cells, CD45 + leukocytes and non-single cells were excluded as described (Sleeman et al 2006 (Sleeman et al , 2007 . Cells incubated in non-specific IgG (conjugated to PE-Cy5 or APC) were used to set the gates that define CD24 + or Sca-1 + cells (respectively). Within the CD24 + population, two separate cell populations were annotated as CD24 +/High and CD24 +/Low (showing approximately 5-fold difference in CD24 expression; Sleeman et al 2006) . Three subfractions of cells (CD24 +/Low Sca-1 -; CD24 +/High Sca-1 -; CD24 +/High Sca-1 + ) were further analyzed for their expression of CD61 and CD14, using a similar strategy to confirm specificity (left hand panels, incubated in FITC-conjugated IgG and PE-conjugated IgG respectively), and enable the quantitative evaluation of cells in each quadrant (shown as % of total cells in that fraction, ± SD, n= three independent sorts). (Sleeman et al 2006) . The stem cell gate shown in panel 5, is positioned at the outer contour line of the 95% linear density contour plot, to include basal cells with the highest levels of CD24 and the highest levels of CD49f. These cells have a repopulation capacity of approximately 1 in 300, whereas the rest of the CD24 +/low population is almost 10x lower in its functional activity (Sleeman et al., 2007) , and the luminal cell population has an activity approximately 1/15,000. Currently, there is no lower limit for enrichment of stem cells. If for example, all of the basal cells are included and the fraction is labeled "stem cells", their functional activity is only 1/3,400 (or 0.03%). The data was redrawn from data presented by (Britt et al., 2009 ).
Figure S6 Example of a report of recovery and fold-enrichment of stem cell activity
The following mammary epithelial cell populations isolated from 3-4 month-old C57Bl6 mice were tested for stem cell activity using limiting dilution of cell suspensions into cleared fat pads of 3 week-old mice: whole cell populations (run through the flow cytometer, but not sorted); the so-called "MRU" fraction (mammary regenerating unit) defined as the top 2% of cells with highest CD49f/CD24 in the basal cell subpopulation (isolated as described in Supplementary Figure 5 , and Badders et al 2009); fractions isolated from total mammary epithelial cell populations based upon their Lrp5 expression (LRP5 high , LRP5 + and LRP5 -). Stem cell frequencies were calculated using the limdil algorithm (as reported) and each fraction is described by the % recovery of activity and the fold enrichment. This data is derived from raw data reported in in (Badders et al 2009) . 
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